Pneumatically actuated integrated life support system

Information

  • Research Project
  • 6485488
  • ApplicationId
    6485488
  • Core Project Number
    R43HL067508
  • Full Project Number
    1R43HL067508-01A1
  • Serial Number
    67508
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/15/2002 - 22 years ago
  • Project End Date
    7/14/2003 - 21 years ago
  • Program Officer Name
    SOPKO, GEORGE
  • Budget Start Date
    7/15/2002 - 22 years ago
  • Budget End Date
    7/14/2003 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    7/12/2002 - 22 years ago
Organizations

Pneumatically actuated integrated life support system

Description (provided by applicant): Ension, Inc. has previously developed integrated blood pump-oxygenator technologies offering many advantages over current clinical systems. In particular, the small size of the integrated devices has been well received by our colleagues in the "MedEvac" field as a potential enabling technology to improve safety of transports with patients on extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass (CPB). Currently, only 1 percent of the MedEvac emergency transport systems in the United States are capable of transporting ECMO or CPB patients due to the physical size, weight, and in-field robustness of the current "portable" electrical systems. Furthermore, our MedEvac colleagues report that the complexity of patient transport is exacerbated by the unreliable discharge characteristics of rechargeable batteries used to power units during portable operation. Preliminary work performed at Ension supports the development of a new, portable, integrated blood pump-oxygenator that is powered solely by a standard source of compressed gas. Compressed gas is used to drive the unit (pump blood) with the exhaust gas redirected into the unit to provide subsequent oxygenation and decarbonation. If ultimately successful, this approach will completely eliminate the need for battery power resulting in a significantly smaller, simpler, and more robust system suitable for emergency transport uses. PROPOSED COMMERCIAL APPLICATION: Less than 1% of the MedEvac emergency transport systems in the United States are capable of transporting patients on ECMO, CPB, or a combination of supportive devices. This is problematic since, as healthcare delivery in the United States continues to move to a hub-and-spoke model, MedEvac transport of such critically ill patients is becoming increasingly necessary. The proposed stechnology will enable these MedEvac systems to begin safe transport of this patient population by addressing the limitations posed by size, weight, and in-field robustness of current ECMO/CPB systems used for this purpose.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    198467
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:198467\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ENSION, INC.
  • Organization Department
  • Organization DUNS
    100758015
  • Organization City
    PITTSBURGH
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    152381328
  • Organization District
    UNITED STATES